Inquiry · Opened 10 April 2025
Addressing the risks from Perfluoroalkyl and Polyfluoroalkyl Substances (PFAS)
From: Environmental Audit Committee
What this inquiry is asking
This inquiry examines whether UK government and regulators are adequately preventing, managing, and remediating contamination from PFAS ('forever chemicals')—persistent synthetic substances used in firefighting foams, non-stick coatings, textiles, and military applications that accumulate in human blood and the environment. The committee is investigating regulatory gaps, health risks, remediation capacity, and whether UK policy lags dangerously behind the EU.
Status / emerging findings
- PFAS are now measurable in every UK resident's blood and contaminate 98% of UK river sites; DEFRA estimates 3,000–10,000 contamination hotspots with cleanup costs of £31–121 billion.
- UK REACH has added zero PFAS substances to restriction lists since January 2021, while the EU added eight; UK restriction timelines average 4–5 years, creating a competitive disadvantage and regulatory uncertainty.
- The Government's April 2026 PFAS Plan lacks decisive prevention measures and relies on a slower, evidence-led, substance-by-substance approach rather than the EU's precautionary class-wide restrictions.
- Firefighting foam (military and civilian) is the priority target for restriction; HSE proposed 18-month to 10-year transition periods with viable alternatives already available for many uses.
- Remediation technology is nascent; most current approaches capture rather than destroy PFAS, and responsibility for cleanup is legally diffuse, with site owners often bearing costs despite contamination from multiple collective sources.
Why it matters
PFAS contamination poses documented health risks (cancer, immune suppression, fertility damage) that are already widespread in UK bodies and water; the committee found the Government's response plan is too slow and weak compared to international standards, creating a legacy cleanup bill of tens of billions while ongoing emissions continue unchecked.
Tone arc
Started cooperative and fact-finding in June 2025 (establishing PFAS ubiquity and regulatory failure), sharpened into adversarial challenge of industry claims and government timidity by September 2025 (manufacturing exemptions, lack of alternatives data), and ended confrontational in February 2026 (tension between UK's cautious, evidence-led approach versus EU's precautionary class-wide bans, and challenges to HSE and Environment Agency capacity).
Themes
Key witnesses
Minister Emma Hardy (DEFRA), Liz Parkes MBE (Health and Safety Executive), Professor Elsie Sunderland (Harvard, global PFAS expert), Professor Martyn Kirk (Australian epidemiologist), Professor Alan Boobis (UK toxicologist), David Henderson (Water UK), Stuart Ede (AGC Chemicals Europe, PFAS manufacturer), Duncan Sanders (ATG Group, remediation)
Reports & Government Responses
Report · 23 April 2026 · HC 852
9th Report - Addressing the risks from Perfluoroalkyl and Polyfluoroalkyl Substances (PFAS)
Witness sessions
Oral evidence · 25 June 2025 · HC 852
Session 1 of 8Oral evidence · 25 June 2025 · HC 852
Session 2 of 8Oral evidence · 10 September 2025 · HC 852
Session 3 of 8Oral evidence · 10 September 2025 · HC 852
Session 4 of 8Oral evidence · 10 December 2025 · HC 852
Session 5 of 8Oral evidence · 10 December 2025 · HC 852
Session 6 of 8Professor Elsie Sunderland; Professor Martyn Kirk; Professor Alan Boobis
Oral evidence · 4 February 2026 · HC 852
Session 7 of 8Oral evidence · 4 February 2026 · HC 852
Session 8 of 8
Themes & actors
Topics across publication summaries
Top organisations & named entities
- Department for Environment, Food and Rural Affairs (DEFRA)·1 reference
- Health and Safety Executive (HSE)·1 reference
- Environmental Audit Committee·1 reference
- Emma Hardy MP (DEFRA Minister for Water and Flooding)·1 reference
- Professor Martyn Kirk (Australian National University)·1 reference
- Professor Elsie Sunderland (Harvard University)·1 reference
- Professor Michael Depledge (European Centre for Environment and Human Health)·1 reference
- European Chemicals Agency (ECHA)·1 reference
Source · parliament.uk inquiry record ↗